Drugs
FDA Approves Relyvirio for ALS Treatment
FDA Approves Relyvirio for ALS Treatment

Relyvirio, a combination therapy comprising sodium phenylbutyrate and taurusodiol, receives FDA approval as a therapeutic option for ALS, designated as an orphan drug.

June 2023

Dupilumab in Children with Uncontrolled Atopic Der
Dupilumab in Children with Uncontrolled Atopic Dermatitis

Biological drug 'highly effective' in reducing symptoms, study finds.

June 2023

Lipid-Lowering and Antidiabetic Drugs May Protect
Lipid-Lowering and Antidiabetic Drugs May Protect Against Macular Degeneration

Cholesterol and diabetes medications demonstrate potential in reducing the risk of age-related macular degeneration, offering hope for preserving eye health in aging populations.

June 2023

Optimizing Urinary Tract Infection Diagnosis
Optimizing Urinary Tract Infection Diagnosis

Learn about the use of urine cultures to minimize unnecessary antibiotic usage and reduce misdiagnosis rates of urinary tract infections.

May 2023

Long-Term Low-Dose Aspirin and AMD
Long-Term Low-Dose Aspirin and AMD

Research aimed at estimating the risk of AMD with regular long-term use of low-dose aspirin.

May 2023

Metformin, Ivermectin, and Fluvoxamine for Covid-1
Metformin, Ivermectin, and Fluvoxamine for Covid-19

None of the Three Drugs in the Trial Prevented a Primary Event

April 2023

Illicit Drug Use and Cardiovascular Risk in the IC
Illicit Drug Use and Cardiovascular Risk in the ICU

Illicit Drug Use Has Increased by 22% in the Last Decade to an Estimated 275 Million People Worldwide

April 2023

WHO Reports 61 Vaccines in Development for Drug-Re
WHO Reports 61 Vaccines in Development for Drug-Resistant Bacterial Diseases

Despite promising advancements, the World Health Organization (WHO) emphasizes the ongoing need to enhance existing vaccine utilization as 61 potential vaccines for drug-resistant bacterial diseases are under development, albeit not immediately available.

March 2023

Lipid-Lowering Drugs Suggest Unexpected Protective
Lipid-Lowering Drugs Suggest Unexpected Protective Benefit Against Hip Fracture Risk

Lipid-lowering drugs are associated with an unexpected protective benefit against the risk of hip fracture, challenging conventional perceptions of their effects on bone health and highlighting potential therapeutic implications.

Februery 2023

Lack of Antimicrobial Innovation Threatens Antibio
Lack of Antimicrobial Innovation Threatens Antibiotic Efficacy, WHO Warns

The WHO warns of dwindling antimicrobial innovation, citing the urgent need for new antibiotic development to combat rising antimicrobial resistance and prevent a public health crisis.

Februery 2023

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health
Top reads...
Syphilis Cases on the Rise Amongst Young People Reevaluating Sunlight Exposure New Study Unveils Effective TB Prevention Strategy Smoking, Alcohol Consumption, and Risk of Incident Diverticulitis Rotator cuff surgery